Company Filing History:
Years Active: 2018-2021
Title: Pei-yun Chang: Innovator in Hematology
Introduction
Pei-yun Chang is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of hematology, particularly in the development of innovative therapies for bleeding disorders. With a total of 4 patents to her name, her work is paving the way for advancements in treatment options.
Latest Patents
Chang's latest patents include groundbreaking inventions such as the "Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof." This invention provides a chimeric protein that comprises a von Willebrand Factor (VWF) protein and a Factor VIII (FVIII) protein, linked with an XTEN sequence. The chimeric protein is designed to extend the half-life of FVIII, which is crucial for effective treatment in patients with bleeding disorders. Another notable patent is the "Factor VIII-XTEN fusions and uses thereof," which focuses on chimeric proteins that enhance the therapeutic efficacy of FVIII by reducing its affinity for VWF, thereby improving treatment outcomes for patients.
Career Highlights
Pei-yun Chang is currently employed at Bioverativ Therapeutics Inc., where she continues to innovate in the field of biotechnology. Her work is instrumental in developing therapies that address critical health challenges related to blood disorders.
Collaborations
Chang collaborates with esteemed colleagues, including Tongyao Liu and Robert T Peters, to further her research and development efforts. These collaborations enhance the potential impact of her inventions in the medical field.
Conclusion
Pei-yun Chang's contributions to hematology through her innovative patents and collaborative efforts are making a significant difference in the treatment of bleeding disorders. Her work exemplifies the importance of innovation in advancing medical science and improving patient care.